• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, May 26, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

New research effort to understand role of APOE mutation in Alzheimer’s disease

Bioengineer by Bioengineer
July 13, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

If you had your genome sequenced and the report says you have the APOEε4 mutation, it does not mean you are definitely going to get Alzheimer's disease.

The reason why is complicated.

The specific genetic variant known as APOEε4 (the ε4 mutation of Apolipoprotein E) is the greatest genetic risk factor for late-onset Alzheimer's disease (AD), the most common form of AD. Inheriting APOEε4 is associated with a 15 to 20 percent increase in the likelihood of developing AD. However, the majority of people who inherit APOEε4 do not get AD, and at least 20 other genes are implicated in the disease.

AD is the sixth leading cause of death in the United States. Currently no treatments are available that prevent or slow the disease. Genetics is thought to account for up to 70% of risk for developing AD, and APOE is only one part of this heritable risk.

In the past, researchers studied the effects of APOEε4 in a few inbred mouse strains. That standardized approach is helpful in working out the molecular mechanisms of the mutation itself, but doesn't demonstrate how APOEε4 operates in different individuals with widely varying genetic backgrounds, as in the human population.

Instead, JAX scientists Michael Sasner, Gregory Carter and Gareth Howell are placing the APOEε4 mutation in mouse populations with a high level of genetic diversity, in order to sort out the complex genetic interactions involved in developing AD. The National Institute on Aging has awarded the JAX researchers a five-year grant totaling $4,191,258 million to fund this effort.

"Previous attempts to model AD in mice have utilized only a tiny fraction of the available genetic diversity," Sasner says, "and we believe this is one of the main reasons why mouse models have failed to recapitulate key aspects of human AD contributing to the lack of success in clinical trials. At JAX, we have access to mouse strains that capture as much genetic diversity as is present in the human population and the expertise to maximize their potential."

###

Media Contact

News
[email protected]
@jacksonlab

http://www.jax.org

https://www.jax.org/news-and-insights/2018/july/apoe-alzheimers-research-grant

Share12Tweet8Share2ShareShareShare2

Related Posts

Microglial Mitochondria Transfer Eases Tauopathy Cognitive Deficits

May 26, 2026

TAK1 Controls Inflammatory Fibroblasts in Heart Attack

May 26, 2026

AI Powers Timely Sepsis Risk in Neonatal ICU

May 26, 2026

Targeting Arginine Metabolism Halts ARID1A-Deficient TNBC

May 26, 2026
Please login to join discussion

POPULAR NEWS

  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    316 shares
    Share 126 Tweet 79
  • New Study Reveals Plants Can Detect the Sound of Rain

    734 shares
    Share 293 Tweet 183
  • Common Food Preservatives Associated with Elevated Blood Pressure and Increased Heart Disease Risk

    56 shares
    Share 22 Tweet 14
  • Research Indicates Potential Connection Between Prenatal Medication Exposure and Elevated Autism Risk

    847 shares
    Share 339 Tweet 212

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Microglial Mitochondria Transfer Eases Tauopathy Cognitive Deficits

High-Speed Hyperspectral Microscopy with Enhanced Resolution

TAK1 Controls Inflammatory Fibroblasts in Heart Attack

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.